The optimal effect site concentration of remifentanil in combination with intravenous midazolam and topical lidocaine for awake fibreoptic nasotracheal intubation in patients undergoing cervical spine surgery

Minerva Anestesiologica

Volumn 78, Issue 5, 2012, Pages 521-526

  Song, J W ^a   Kwak, Y L ^a   Lee, J W ^a   Chang, C H ^a   Kim, H S ^a   Shim, Y H ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Analgesics; Anesthesia; Conscious sedation; Opioid

Indexed keywords

LIDOCAINE; MIDAZOLAM; REMIFENTANIL;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CERVICAL SPINE INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONSCIOUS SEDATION; COUGHING; DRUG EFFECT; DRUG INFUSION; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; MEDIAN EFFECTIVE CONCENTRATION; NASOTRACHEAL INTUBATION; PATIENT SATISFACTION;

ADMINISTRATION, TOPICAL; ANESTHETICS, COMBINED; ANESTHETICS, INTRAVENOUS; ANESTHETICS, LOCAL; CERVICAL VERTEBRAE; CONSCIOUS SEDATION; FEMALE; FIBER OPTIC TECHNOLOGY; HUMANS; INTUBATION, INTRATRACHEAL; LIDOCAINE; MALE; MIDAZOLAM; MIDDLE AGED; PIPERIDINES;

EID: 84860285199     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fuchs G, Schwarz G, Baumgartner A, Kaltenbock F, Voit-Augustin H, Planinz W. Fiberoptic intubation in 327 neurosurgical patients with lesions of the cervical spine. J Neurosurg Anesthesiol 1999;11:11-6.
2. Langford RA, Leslie K. Awake fibreoptic intubation in neurosurgery. J Clin Neurosci 2009;16:366-72.
3. Woodall NM, Harwood RJ, Barker GL. Complications of awake fibreoptic intubation without sedation in 200 healthy anaesthetists attending a training course. Br J Anaesth 2008;100:850-5.
4. Walsh ME, Shorten GD. Preparing to perform an awake fiberoptic intubation. Yale J Biol Med 1998;71:537-49.
5. Lauwers M, Camu F, Breivik H, Hagelberg A, Rosen M, Sneyd R et al. The safety and effectiveness of remifentanil as an adjunct sedative for regional anesthesia. Anesth Analg 1999;88:134-40.
6. Burkle H, Dunbar S, Van Aken H. Remifentanil: a novel, short-acting, mu-opioid. Anesth Analg 1996;83:646-51.
7. Puchner W, Egger P, Puhringer F, Lockinger A, Obwegeser J, Gombotz H. Evaluation of remifentanil as single drug for awake fiberoptic intubation. Acta Anaesthesiol Scand 2002;46:350-4.
8. Egan TD. Target-controlled drug delivery: progress toward an intravenous "vaporizer" and automated anesthetic administration. Anesthesiology 2003;99:1214-9.
9. Reusche MD, Egan TD. Remifentanil for conscious sedation and analgesia during awake fiberoptic tracheal intubation: a case report with pharmacokinetic simulations. J Clin Anesth 1999;11:64-8.
10. Donaldson AB, Meyer-Witting M, Roux A. Awake fibreoptic intubation under remifentanil and propofol targetcontrolled infusion. Anaesth Intensive Care 2002;30:93-5.
11. Machata AM, Gonano C, Holzer A, Andel D, Spiss CK, Zimpfer M et al. Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and hemodynamic stability during conscious sedation with remifentanil. Anesth Analg 2003;97:904-8.
12. Cafiero T, Esposito F, Fraioli G, Gargiulo G, Frangiosa A, Cavallo LM et al. Remifentanil-TCI and propofol-TCI for conscious sedation during fibreoptic intubation in the acromegalic patient. Eur J Anaesthesiol 2008;25:670-4.
13. Mingo OH, Ashpole KJ, Irving CJ, Rucklidge MW. Remifentanil sedation for awake fibreoptic intubation with limited application of local anaesthetic in patients for elective head and neck surgery. Anaesthesia 2008;63:1065-9.
14. Rai MR, Parry TM, Dombrovskis A, Warner OJ. Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. Br J Anaesth 2008;100:125-30.
15. Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJ, Gambus PL et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997;86:10-23.
16. Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol 1990;10:244-51.
17. Dixon WJ. Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev 1991;15:47-50.
18. De Castro V, Godet G, Mencia G, Raux M, Coriat P. Target-controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement. Anesth Analg 2003;96:33-8.
19. Moerman AT, Herregods LL, De Vos MM, Mortier EP, Struys MM. Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients. Anesth Analg 2009;108:828-34.
20. Avramov MN, Smith I, White PF. Interactions between midazolam and remifentanil during monitored anesthesia care. Anesthesiology 1996;85:1283-9.